Evaluating the effectiveness of telehealth for buprenorphine treatment in opioid use disorder
Official title: Evaluating real-world effectiveness of tele-buprenorphine: A mixed-methods study to develop clinical guidance
Funded at University of Michigan at Ann Arbor · NIH-11163301 · Data updated 2026-11-12
This study is looking at how well telehealth treatment with buprenorphine works for people with opioid use disorder, especially for those who might have a harder time getting help, and it wants to hear from patients about their experiences to improve care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 15, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $675,731 |
| NIH project number | 5R01DA060942-02 |
| Project ID | NIH-11163301 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals with opioid use disorder, especially those who may benefit from telehealth services.
✕Less likely to help
Patients who are not experiencing opioid use disorder or those who do not have access to telehealth services may not benefit from this research.
What this research studies
This research investigates how effective telehealth-delivered buprenorphine treatment is for individuals with opioid use disorder (OUD). It aims to gather real-world data on the effectiveness of this treatment, especially for high-risk groups and those facing treatment disparities. By using innovative methods to analyze existing data, the study seeks to provide clinical guidance on the best ways to implement tele-buprenorphine in various healthcare settings. Patients may be involved in discussions about their treatment experiences and outcomes.
Why it matters
Potential benefit: If successful, this research could improve access to effective treatment for opioid use disorder, particularly for underserved populations.
How similar studies have gone: While telehealth for substance use treatment is a growing field, this specific approach to evaluating tele-buprenorphine effectiveness is relatively novel and has not been extensively tested in prior studies.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Lin, Lewei Allison — University of Michigan at Ann Arbor
- Study coordinator: Lin, Lewei Allison
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.